Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-1.93%||69.07||1.0%||$465.79m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.13%||618.11||2.7%||$392.67m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.10%||230.84||1.9%||$334.35m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.00%||2.88||0.7%||$201.32m|
|EXAS||EXACT Sciences Corp.||-1.67%||76.13||17.9%||$160.64m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.51%||91.51||13.7%||$138.71m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-0.41%||138.62||8.2%||$131.51m|
|BBIO||BridgeBio Pharma, Inc.||-0.51%||11.70||0.0%||$104.26m|
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Protein Sciences and Diagnostics &Genomics. The Protein Sciences segment develops and manufactures purified proteins and reagent solutions most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. This segment also includes protein analysis solutions that offer researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics &Genomics segment develops and manufactures diagnostic products, including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx Prostate(IntelliScore) test (EPI) for prostate cancer diagnosis. This segment also manufactures and sells advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use. The company was founded in 1976 and is headquartered in Minneapolis, MN.